Media & Press
In the
Press
Dr. Suraj Malhan is available for media interviews, podcast appearances, expert commentary, and keynote engagements. For all press and media inquiries, contact the team directly.
Credentials
Fellowship-Trained Neurologist · Jefferson Headache Center
Clinical Asst. Professor · Rutgers RWJMS / RWJBarnabas Health
Medical Advisory Board · Miles for Migraine
First Author · MedLink Neurology
Platform
500K+ followers across Instagram, TikTok, YouTube & Facebook
20M+ views on brain health content
One of the world's most-followed neurologists on social media
Press Coverage
Featured In &
Quoted By
Health
Quoted Expert · Print & Digital
GLP-1 Drugs May Have Another Potential Benefit — For Migraine
Dr. Malhan was quoted discussing emerging research on GLP-1 receptor agonists and migraine. An emerging study analyzing nearly 22,000 patients with chronic migraine found that GLP-1 receptor agonists were associated with fewer emergency visits, hospitalizations, and escalation to additional preventive medications compared with topiramate — highlighting a potential connection between metabolic pathways and migraine.
Read Article ↗Coming
Soon
More press features coming soon
Social Platforms
Follow Dr. Malhan
Online
Available to Speak On
Speaking Topics
for Media & Podcasts
The lifestyle and health factors linked to dementia risk — and practical strategies for lifelong brain health.
Why migraine is one of the world's leading causes of disability — and how CGRP therapies and neuromodulation are transforming care.
How the brain adapts, grows, and protects itself — and what this means for focus, learning, and aging.
The neuroscience of sleep and chronic stress — and evidence-based strategies for cognitive resilience.
How physician creators and AI are reshaping health education — and what responsible science communication looks like at scale.
How physicians can build trust and grow a meaningful digital presence while maintaining scientific credibility.
Media &
Press
Inquiries
Dr. Malhan is available for podcast interviews, expert commentary, keynote engagements, and media features. His team responds to all serious media inquiries within 48 hours.